Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 2 Multiple Myeloma 2 Recurrence 1 Platinum-resistant Ovarian Cancer 1 Ovarian Cancer Recurrent 1 Lymphoma 1 Hematologic Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Advanced Malignancies 1 Adenoviridae Infections 1

Interventions

pembrolizumab 1 liposomal doxorubicin 1 fludarabine phosphate 1 atezolizumab 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Adenoviridae Infections × 1-dodecylpyridoxal × Clear all

NCT05271318 2026-05-05

PROTA

TILT Biotherapeutics Ltd.

Phase 1/2 Active not recruiting

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡